Antistreptococcal response is exaggerated in children with familial Mediterranean fever

Clinical Rheumatology

Volumn 21, Issue 5, 2002, Pages 378-381

  Yalcinkaya F ^a   Ince, E ^a   Ucar T ^a   Ozkaya N ^a   Tekin, M ^a   Elhan, A H ^a   Tutar, E ^a   Guriz D H ^a   Aysev, D ^a   Gokdemir R ^a   Dogru U ^a   Tumer N ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Antideoxyribonuclease B; Antistreptolysin O; Familial Mediterranean fever; Streptococcal pharyngitis

Indexed keywords

ANTISTREPTOLYSIN; BACTERIUM ANTIBODY; DEOXYRIBONUCLEASE; ENZYME ANTIBODY; STREPTOCOCCUS ANTIGEN;

ADOLESCENT; ADULT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BETA HEMOLYTIC STREPTOCOCCUS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FAMILIAL MEDITERRANEAN FEVER; FEMALE; HUMAN; MALE; MEDICAL DOCUMENTATION; PHARYNGITIS; PRIORITY JOURNAL; RHEUMATIC FEVER; THROAT CULTURE; UPPER RESPIRATORY TRACT INFECTION;

ADOLESCENT; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, BACTERIAL; ANTISTREPTOLYSIN; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FAMILIAL MEDITERRANEAN FEVER; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; PHARYNGITIS; PROBABILITY; REFERENCE VALUES; RISK ASSESSMENT; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

EID: 0036741092     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100670200101     Document Type: Article

References (17)

1. Samuels J, Aksentijevich I, Torosyan Y et al. Familial Mediterranean fever at the millennium. Clinical spectrum, ancient mutations and a survey of 100 American referrals to the National Institutes of Health. Medicine 1998;77:268-97.
2. Veasy G, Hill HR. Immunologic and clinical correlations in rheumatic fever and rheumatic heart disease. Pediatr Infect Dis J 1997;16:400-7.
3. Ehrenfeld EN, Eliakim M, Rachmilewitz M. Recurrent polyserositis (Familial Mediterranean fever; periodic disease). Am J Med 1961;31:107-23.
4. Shapiro TR, Ehrenfeld EN. Recurrent polyserositis ('periodic disease,' 'Familial Mediterranean Fever') in children. Pediatrics 1962;30:443-9.
5. Eliakim M, Rachmilewitz M, Rosenman E, Niv A. Renal manifestations in recurrent polyserositis. Israel J Med Sci 1970;6:228-45.
6. Yalçinkaya F, Tümer N. Glomerular lesions other than amyloidosis in patients with familial Mediterranean fever. Nephrol Dial Transplant 1999;14:21-3.
7. Eliakim M, Levy M, Ehrenfeld M. Eds. Recurrent polyserositis. Amsterdam: Elsevier North Holland, 1981:32-4.
8. Tekin M, Yalçinkaya F, Tümer N, Cakar N, Koçak H. Familial Mediterranean fever and acute rheumatic fever: A pathogenetic relationship? Clinical Rheumatol 1999;18:446-9.
9. Livneh A, Langevitz P, Zemer D et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 1997;40:1879-85.
10. Akar N, Misirlioǧlu M, Yalçinkaya F et al. MEFV mutations in Turkish patients suffering from familial Mediterranean fever. Hum Mutat 2000;15:118-19.
11. Morell A, Doran JE, Skveril F. Ontogeny of the Immoral response to group A streptococcal carbohydrate: class and Ig G subclass composition of antibodies in children. Eur J Immunol 1990;20:1513-17.
12. Ayoub E, Wannamaker L. Evaluation of streptococcal deoxyribonuclease B and diphosphopyridine nucleotidase antibody tests in acute rheumatic fever and acute glomerulonephritis. Pediatrics 1962;29;527-38.
13. Kaplan EL, Rothermel CD, Johnson DR. Antistreptolysin O and antideoxyribonuclease B titers: normal values for children ages 2 to 12 in the United States. Pediatrics 1998;101:86- 8.
14. Ince E, Cakar N, Tekin M et al. Arthritis in children with familial Mediterranean fever. Rheumatol Int 2002 (in press).
15. Ayoub EM, Ahmed S. Update on complications of group A streptococcal infections. Curr Probl Pediatr 1997;27:90-101.
16. Zabriskie JB, Hsu KC, Seegal BC. Heart-reactive antibody associated with rheumatic fever: characterisation and diagnostic significance. Clin Exp Immunol 1970;7:147-59.
17. Gibofsky A, Kerwar S, Zabriskie JB. Rheumatic fever. The relationship between host, microbe, and genetics. Rheum Dis Clin North Am 1998;24:237-59.